Unresectable Locally Advanced Pancreatic Carcinoma

Oncology
0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

OncoSil Medical
OncoSil MedicalAustralia - Macquarie Park
2 programs
OncoSil™N/A1 trial
OncoSil™N/A1 trial
Active Trials
NCT03003078CompletedEst. Jul 2020
NCT03076216CompletedEst. Nov 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
OncoSil MedicalOncoSil™
OncoSil MedicalOncoSil™

Clinical Trials (2)

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.

Start: Aug 2017Est. completion: Nov 2020
N/ACompleted

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane

Start: Mar 2017Est. completion: Jul 2020
N/ACompleted

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space